Cristin-person-ID: 22674
Person

Ellen Mengshoel Brevik

  • Stilling:
    Seniorforsker
    ved Radiofarmasøytisk FoU ved Institutt for energiteknikk

Kontaktinformasjon

Telefon
22855709

Resultater Resultater

Effective treatment of microscopic cancers with Tb-161.

Rusten, Øystein Arne Johnsen; Brevik, Ellen Mengshoel; Hassfjell, Sindre; Tkacz-Stachowska, Kinga Magda; Hjelstuen, Olaug; Tønnesen, Hanne Hjorth. 2018, EJNMMI Radiopharmacy and Chemistry. IFE, UIOSammendrag/abstract

Development of targeted radiopharmaceuticals with terbium-161for use in radioimmunotherapy.

Skåre, K. Eckell; Brevik, Ellen Mengshoel; Hassfjell, Sindre Petter; Tkacz-Stachowska, Kinga Magda; Hjelstuen, Olaug. 2018, EJNMMI Radiopharmacy and Chemistry. IFESammendrag/abstract

Small compounds for targeted radiotherapy.

Brevik, Ellen Mengshoel. 2007, Unipub forlag. SINTEF, UIODoktorgradsavhandling

Repeated therapy of HER2-expressing breast and ovarian cancer xenografts in mice with targeted low dose rate alpha emitting Th-227-DOTA-p-benzyl-trastuzumab.

Heyerdahl, Helen; Brevik, Ellen Mengshoel; Borrebæk, Jørgen; Larsen, Åsmund; Dahle, Jostein. 2010, European Journal of Nuclear Medicine and Molecular Imaging. OUS, ALGETASammendrag/abstract

Radioimmunotherapy of Mice with HER-2 Positive SKOV-3 Xenografts Using Th-227- and Lu-177-labeled p-benzyl-DOTA-trastuzumab.

Abbas, Nasir; Bruland, Øyvind; Borrebæk, Jørgen; Larsen, Åsmund; Brevik, Ellen Mengshoel; Dahle, Jostein. 2010, European Journal of Nuclear Medicine and Molecular Imaging. OUS, ALGETASammendrag/abstract
1 - 5 av 8 | Neste | Siste »